Show simple item record

dc.contributor.authorBlockman, M.
dc.contributor.authorCohen, K. 
dc.contributor.authorDe Waal, R.
dc.contributor.authorGray, A.
dc.contributor.authorKredo, T.
dc.contributor.authorMaartens, G.
dc.contributor.authorNel, J.
dc.contributor.authorParrish, A.
dc.contributor.authorRees, H.
dc.contributor.authorReubenson, G.
dc.date.accessioned2020-07-20T09:04:36Z
dc.date.available2020-07-20T09:04:36Z
dc.date.issued2020-06-25
dc.identifier.urihttps://infospace.mrc.ac.za/handle/11288/595267
dc.language.isoenen_US
dc.publisherSouth African National Department of Healthen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleFavipiravir for the prevention and management of COVID‐19: evidence review of the clinical benefit and harmen_US
dc.typeArticleen_US
dc.contributor.departmentCochrane South Africa, South  African Medical Research Councilen_US
dc.research.unitSouth African Cochrane Centreen_US
dc.date.epub2020-06-25


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States